Graphique du cours de l'action PBM
PBM Dividendes
Psyence Biomedical Ltd
$3.06
-1.29%
$-0.04
À la fermeture : Jun 30, 16:00:00 GMT-4
$3.01
-1.59%
$-0.04
Post-Marché: Jun 30, 19:12:29 GMT-4
Retour
Psyence Biomedical Ltd (PBM) Dividendes
Statistiques clés
Clôture préc.
$3.1
Prix d'ouverture
$3.04
Plage de la journée
$3.01 - $3.19
Plage de 52 semaines
$1.92 - $468.38
Volume
24.8K
Volume moyen
1.8M
Rendement en dividend
--
BPA (TTM)
1612.60
Capitalisation boursière
$6.9M
Qu’est-ce que PBM ?
Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Fonctionnalités
© 2026 Edgen fonctionné par
